Home >> Pharmaceuticals >> Food & Beverage >>

EMEA All Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Published: Sep-2017 | Format: PDF | Global Info Research | Number of pages: 122 | Code: MRS - 168573

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).


Scope of the Report:
This report focuses on the All Vaccine in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    CNBG
    ChengDa Bio
    Changsheng Life
    Zhifei
    SINOVAC BIOTECH
    NuoCheng Bio
    Hualan Bio
    Kangtai
    SANOFI PASTEUR S.A.
    Novartis
    GSK

Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
    Varicella
    Influenza
    Polio
    Hepatitis A
    Rabies
    BCG
    Hepatitis B
    Pertussis, Diphtheria, tetanus
    Pneumococcal
    Other

Market Segment by Applications, can be divided into
    For Adult
    For Child

There are 13 Chapters to deeply display the EMEA All Vaccine market.

Chapter 1, to describe All Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of All Vaccine, with sales, revenue, and price of All Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of All Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, All Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe All Vaccine research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Table of Contents
1 Market Overview
    1.1 All Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Varicella
        1.2.2 Influenza
        1.2.3 Polio
        1.2.4 Hepatitis A
        1.2.5 Rabies
        1.2.6 BCG
        1.2.7 Hepatitis B
        1.2.8 Pertussis, Diphtheria, tetanus
        1.2.9 Pneumococcal
        1.2.10 Other
    1.3 Market Analysis by Applications
        1.3.1 For Adult
        1.3.2 For Child
    1.4 Market Analysis by Regions
        1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
            1.4.1.1 Germany Market States and Outlook (2012-2022)
            1.4.1.2 France Market States and Outlook (2012-2022)
            1.4.1.3 UK Market States and Outlook (2012-2022)
            1.4.1.4 Italy Market States and Outlook (2012-2022)
            1.4.1.5 Russia Market States and Outlook (2012-2022)
            1.4.1.6 Turkey Market States and Outlook (2012-2022)
        1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
            1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.2.2 UAE Market States and Outlook (2012-2022)
            1.4.2.3 Israel Market States and Outlook (2012-2022)
            1.4.2.4 Iran Market States and Outlook (2012-2022)
        1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
            1.4.3.1 South Africa Market States and Outlook (2012-2022)
            1.4.3.2 Nigeria Market States and Outlook (2012-2022)
            1.4.3.3 Egypt Market States and Outlook (2012-2022)
            1.4.3.4 Algeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 CNBG
        2.1.1 Business Overview
        2.1.2 All Vaccine Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 CNBG All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 ChengDa Bio
        2.2.1 Business Overview
        2.2.2 All Vaccine Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 ChengDa Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Changsheng Life
        2.3.1 Business Overview
        2.3.2 All Vaccine Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Changsheng Life All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Zhifei
        2.4.1 Business Overview
        2.4.2 All Vaccine Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Zhifei All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 SINOVAC BIOTECH
        2.5.1 Business Overview
        2.5.2 All Vaccine Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 SINOVAC BIOTECH All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 NuoCheng Bio
        2.6.1 Business Overview
        2.6.2 All Vaccine Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 NuoCheng Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Hualan Bio
        2.7.1 Business Overview
        2.7.2 All Vaccine Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Hualan Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Kangtai
        2.8.1 Business Overview
        2.8.2 All Vaccine Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Kangtai All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 SANOFI PASTEUR S.A.
        2.9.1 Business Overview
        2.9.2 All Vaccine Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 SANOFI PASTEUR S.A. All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Novartis
        2.10.1 Business Overview
        2.10.2 All Vaccine Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Novartis All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 GSK
        2.11.1 Business Overview
        2.11.2 All Vaccine Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 GSK All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA All Vaccine Market Competition, by Manufacturer
    3.1 EMEA All Vaccine Sales and Market Share by Manufacturer
    3.2 EMEA All Vaccine Revenue and Market Share by Manufacturer
    3.3 EMEA All Vaccine Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 All Vaccine Manufacturer Market Share
        3.4.2 Top 5 All Vaccine Manufacturer Market Share
    3.5 Market Competition Trend
4 EMEA All Vaccine Market Analysis by Regions
    4.1 EMEA All Vaccine Sales, Revenue and Market Share by Regions
        4.1.1 EMEA All Vaccine Sales by Regions (2012-2017)
        4.1.2 EMEA All Vaccine Revenue by Regions (2012-2017)
    4.2 Europe All Vaccine Sales and Growth (2012-2017)
    4.3 Middle East All Vaccine Sales and Growth (2012-2017)
    4.4 Africa All Vaccine Sales and Growth (2012-2017)
5 Europe All Vaccine by Countries, Type, Application and Manufacturers
    5.1 Europe All Vaccine Sales, Revenue and Market Share by Countries
        5.1.1 Europe All Vaccine Sales by Countries (2012-2017)
        5.1.2 Europe All Vaccine Revenue by Countries (2012-2017)
        5.1.3 Germany All Vaccine Sales and Growth (2012-2017)
        5.1.4 France All Vaccine Sales and Growth (2012-2017)
        5.1.5 UK All Vaccine Sales and Growth (2012-2017)
        5.1.6 Russia All Vaccine Sales and Growth (2012-2017)
        5.1.7 Italy All Vaccine Sales and Growth (2012-2017)
        5.1.8 Turkey All Vaccine Sales and Growth (2012-2017)
    5.2 Europe All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
        5.2.1 Europe All Vaccine Sales by Manufacturers (2016-2017)
        5.2.2 Europe All Vaccine Revenue by Manufacturers (2016-2017)
    5.3 Europe All Vaccine Sales by Type (2012-2017)
    5.4 Europe All Vaccine Sales by Application (2012-2017)
6 Middle East All Vaccine by Countries, Type, Application and Manufacturers
    6.1 Middle East All Vaccine Sales, Revenue and Market Share by Countries
        6.1.1 Middle East All Vaccine Sales by Countries (2012-2017)
        6.1.2 Middle East All Vaccine Revenue by Countries (2012-2017)
        6.1.3 Saudi Arabia All Vaccine Sales and Growth (2012-2017)
        6.1.4 Israel All Vaccine Sales and Growth (2012-2017)
        6.1.5 UAE All Vaccine Sales and Growth (2012-2017)
        6.1.6 Iran All Vaccine Sales and Growth (2012-2017)
    6.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
        6.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
        6.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
    6.3 Middle East All Vaccine Sales by Type (2012-2017)
    6.4 Middle East All Vaccine Sales by Application (2012-2017)
7 Africa All Vaccine by Countries, Type, Application and Manufacturers
    7.1 Africa All Vaccine Sales, Revenue and Market Share by Countries
        7.1.1 Africa All Vaccine Sales by Countries (2012-2017)
        7.1.2 Africa All Vaccine Revenue by Countries (2012-2017)
        7.1.3 South Africa All Vaccine Sales and Growth (2012-2017)
        7.1.4 Nigeria All Vaccine Sales and Growth (2012-2017)
        7.1.5 Egypt All Vaccine Sales and Growth (2012-2017)
        7.1.6 Algeria All Vaccine Sales and Growth (2012-2017)
    7.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
        7.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
        7.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
    7.3 Middle East All Vaccine Sales by Type (2012-2017)
    7.4 Middle East All Vaccine Sales by Application (2012-2017)
8 EMEA All Vaccine Market Segment by Type
    8.1 EMEA All Vaccine Sales, Revenue and Market Share by Type (2012-2017)
        8.1.1 EMEA All Vaccine Sales and Market Share by Type (2012-2017)
        8.1.2 EMEA All Vaccine Revenue and Market Share by Type (2012-2017)
    8.2 Varicella Sales Growth and Price
        10.2.1 EMEA Varicella Sales Growth (2012-2017)
        10.2.2 EMEA Varicella Price (2012-2017)
    8.3 Influenza Sales Growth and Price
        10.3.1 EMEA Influenza Sales Growth (2012-2017)
        10.3.2 EMEA Influenza Price (2012-2017)
    8.4 Polio Sales Growth and Price
        10.4.1 EMEA Polio Sales Growth (2012-2017)
        10.4.2 EMEA Polio Price (2012-2017)
    8.5 Hepatitis A Sales Growth and Price
        10.5.1 EMEA Hepatitis A Sales Growth (2012-2017)
        10.5.2 EMEA Hepatitis A Price (2012-2017)
    8.6 Rabies Sales Growth and Price
        10.6.1 EMEA Rabies Sales Growth (2012-2017)
        10.6.2 EMEA Rabies Price (2012-2017)
    8.7 BCG Sales Growth and Price
        10.7.1 EMEA BCG Sales Growth (2012-2017)
        10.7.2 EMEA BCG Price (2012-2017)
    8.8 Hepatitis B Sales Growth and Price
        10.8.1 EMEA Hepatitis B Sales Growth (2012-2017)
        10.8.2 EMEA Hepatitis B Price (2012-2017)
    8.9 Pertussis, Diphtheria, tetanus Sales Growth and Price
        10.9.1 EMEA Pertussis, Diphtheria, tetanus Sales Growth (2012-2017)
        10.9.2 EMEA Pertussis, Diphtheria, tetanus Price (2012-2017)
    8.10 Pneumococcal Sales Growth and Price
        10.10.1 EMEA Pneumococcal Sales Growth (2012-2017)
        10.10.2 EMEA Pneumococcal Price (2012-2017)
    8.11 Other Sales Growth and Price
        8.11.1 EMEA Other Sales Growth (2012-2017)
        8.11.2 EMEA Other Price (2012-2017)
9 EMEA All Vaccine Market Segment by Application
    9.1 EMEA All Vaccine Sales Market Share by Application (2012-2017)
    9.2 For Adult Sales Growth (2012-2017)
    9.3 For Child Sales Growth (2012-2017)
10 EMEA All Vaccine Market Forecast (2017-2022)
    10.1 EMEA All Vaccine Sales, Revenue and Growth Rate (2017-2022)
    10.2 All Vaccine Market Forecast by Regions (2017-2022)
        10.2.1 Europe All Vaccine Market Forecast by Regions (2017-2022)
            10.2.1.1 Germany All Vaccine Sales Forecast 2017-2022
            10.2.1.2 France All Vaccine Sales Forecast 2017-2022
            10.2.1.3 UK All Vaccine Sales Forecast 2017-2022
            10.2.1.4 Russia All Vaccine Sales Forecast 2017-2022
            10.2.1.5 Italy All Vaccine Sales Forecast 2017-2022
            10.2.1.6 Turkey All Vaccine Sales Forecast 2017-2022
        10.2.2 Middle East Market Forecast by Regions (2017-2022)
            10.2.2.1 Saudi Arabia All Vaccine Sales Forecast 2017-2022
            10.2.2.2 Israel All Vaccine Sales Forecast 2017-2022
            10.2.2.3 UAE All Vaccine Sales Forecast 2017-2022
            10.2.2.4 Iran All Vaccine Sales Forecast 2017-2022
        10.2.3 Africa Market Forecast by Regions (2017-2022)
            10.2.3.1 South Africa All Vaccine Sales Forecast 2017-2022
            10.2.3.2 Nigeria All Vaccine Sales Forecast 2017-2022
            10.2.3.3 Egypt All Vaccine Sales Forecast 2017-2022
            10.2.3.4 Algeria All Vaccine Sales Forecast 2017-2022
    10.3 All Vaccine Market Forecast by Type (2017-2022)
    10.4 All Vaccine Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
    11.1 Sales Channel
        11.1.1 Direct Marketing
        11.1.2 Indirect Marketing
        11.1.3 Marketing Channel Future Trend
    11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
    13.1 Methodology
    13.2 Analyst Introduction
    13.3 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)4480 View Pricing